Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Oct 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 62026801000001112 | Co-prenozide (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 62026901000001118 | Co-prenozide | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Co-prenozide | Is a | Virtual therapeutic moiety | true | Inferred relationship | Existential restriction modifier | ||
| Co-prenozide | Is a | Product containing cyclopenthiazide and oxprenolol | true | Inferred relationship | Existential restriction modifier | ||
| Co-prenozide | Has active ingredient | Oxprenolol | true | Inferred relationship | Existential restriction modifier | ||
| Co-prenozide | Has active ingredient | Cyclopenthiazide | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oxprenolol+cyclopenthiazide 160mg/250mcg m/r tablet | Is a | False | Co-prenozide | Inferred relationship | Existential restriction modifier | |
| Co-prenozide 160mg/0.25mg modified-release tablets | Is a | False | Co-prenozide | Inferred relationship | Existential restriction modifier | |
| Co-prenozide 160mg/0.25mg modified-release tablets | Is a | True | Co-prenozide | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR